HK1176960B - Elastomeric rubber and rubber products without the use of vulcanizing accelerators and sulfur - Google Patents

Description

Elastomeric rubber and rubber product without vulcanization accelerator and sulfur

Cited documents:

foreign patent documents

Patent document 1: U.S. patent No. 5014362.

Patent document 2: japanese patent publication No. 53-125139.

Patent document 3: japanese patent publication No. 52-121653.

Patent document 4: japanese patent publication No. 53-85842.

Patent document 5: japanese patent publication No. 8-19264.

Patent document 6: japanese patent No.3517246, Japanese patent instruction No. 2000-503292.

Patent document 7: japanese patent application laid-open No. 2002-527632.

Patent document 8: U.S. Pat. No.6673871B2, Japanese patent publication No. 2004-526063.

Patent document 9: japanese patent application laid-open No. 2008-512626.

Patent document 10: japanese patent open publication No. 2008-545814.

Patent document 11: U.S. patent No. 7005478.

Other publications

Document 1: "Cross-linkingbarcodedinierdippedfilms", AndrewKells and BobGrobes, LATEX24-25, 1 month 2006, Frankfurt, Germany.

Document 2: "Tailored synthetic ligands: newapachroacforhinoft and together with glex 23-24, month 1 2008, Madrid, spain.

Technical Field

The present invention relates to an elastomeric rubber glove product made from a crosslinked elastomeric rubber film produced by creating a deposit of a composition prepared by adding methacrylic acid to a carboxylated acrylonitrile butadiene latex or using a self-crosslinked carboxylated acrylonitrile butadiene latex on a mold or former and subjecting the deposit to a vulcanization process without the use of vulcanization accelerators and free sulfur.

Background

Natural rubber latex has been used for many years to make dipped latex products such as rubber medical gloves. The natural rubber latex medical gloves so produced have excellent elastic properties and superior protective properties against the transmission of blood borne pathogens. The manufacture of natural rubber gloves involves a vulcanization process whereby monomeric sulfur, which acts as a vulcanizing agent, and chemicals, which act as accelerators in the vulcanization process, are added to the natural rubber latex. More specifically, in the manufacture of rubber gloves, a mold or former in the shape of a hand is dipped one or more times into a natural rubber latex emulsion compounded with added sulfur and accelerators until a rubber film of the desired thickness is deposited. The rubber glove having the desired thickness is then dried and vulcanized at elevated temperature. The vulcanization process is necessary to impart high elastic properties to the natural rubber film. The resulting rubber glove product made from natural rubber latex has advantageous protective, mechanical and physical properties.

Natural rubber latex contains less than 5% non-rubber such as proteins, lipids and trace elements. It is also recognized that the increased use of natural rubber latex medical gloves in hospital settings leads to type I hypersensitivity in some users. The immediate type I hypersensitivity of natural rubber latex glove users is caused by residual extractable latex proteins present in natural rubber gloves. Immediate hypersensitivity usually occurs less than 2 hours after contact and is an allergic reaction mediated by IgE (antibodies found in the circulation). On the skin, this may be in the form of hives that move beyond the range of contact points with latex. Systemic allergic symptoms may include itching of the eyes, swelling of the lips or tongue, choking, dizziness, abdominal pain, vomiting, hypotension and very rarely anaphylactic shock. It has been suggested that persons who have developed allergies caused by natural rubber latex proteins avoid re-exposure to natural rubber latex and products made from natural rubber latex.

Synthetic latexes such as nitrile latex, carboxylated nitrile latex, polychloroprene latex or polybutadiene latex are protein-free. It is therefore recommended for those who have developed protein allergies to use only synthetic latex gloves made from nitrile latex, carboxylated nitrile latex, polychloroprene latex or polybutadiene latex. Some gloves made from these synthetic latexes are reported to have the same or better physical properties than natural rubber latex gloves, but the protective properties of synthetic latex gloves are not as good as those of natural rubber latex gloves.

The synthetic rubber medical gloves are made using almost the same process as used in the manufacture of natural rubber latex medical gloves.

Using the same procedure, a thin film of a synthetic elastomer latex compound having the desired thickness is deposited on a mold or former having a hand shape, dried and vulcanized, whereby the resulting thin elastomeric rubber glove product has the desired mechanical and physical properties. To this end, various synthetic elastomeric gloves have been developed and introduced into the market. Carboxylated nitrile rubber is the most common material used to make synthetic rubber gloves.

The production of rubber gloves made from natural rubber latex and synthetic latex frequently uses an accelerated sulfur vulcanization system in which chemicals such as dithiocarbamates, tetramethylthiuram disulfides, and Mercaptobenzothiazole (MBT) are used as accelerators in the sulfur-based vulcanization process. These accelerators, as the name suggests, serve to increase the rate of vulcanization. Without the use of accelerators, the vulcanization process using sulfur alone would be very slow, requiring several hours at high temperatures of 140 ℃.

The widespread use of these accelerators in the rubber glove manufacturing industry creates other health related problems. These accelerators produce delayed type IV hypersensitivity such as allergic contact dermatitis. This delayed type IV hypersensitivity typically occurs 24-72 hours after contact. The reaction is usually localized rashes, redness of the skin, sometimes accompanied by skin breakdown and blistering, usually on the waist or on the hands.

Thus, if a nitrile glove is found to have an excess of residual accelerator, converting a natural rubber latex glove to a nitrile latex glove to avoid type I hypersensitivity may induce type IV hypersensitivity to occur. Therefore, the industry has sought to make synthetic gloves that do not use a sulfur vulcanization system and therefore avoid the use of accelerators. Thus, in the case of carboxylated nitrile latexes, crosslinking without the use of sulfur and accelerators involves a unique unconventional process that requires the participation of the ionic as well as covalent bond crosslinking mechanisms by the zinc ions present, for example, in zinc oxide. Despite the difficulties of this technology, there is still a great need for this technology. This is the subject of the present invention.

U.S. Pat. No.5014362 (patent document 1 as in the specification) describes a carboxylated nitrile rubber which is subjected to a vulcanization process by means of zinc oxide and sulfur.

Carboxylated nitrile rubbers typically contain acrylonitrile, butadiene, and organic acid segments in various compositional ratios. The use of sulfur and accelerators can produce covalent crosslinking in the butadiene subchains. Also, sulfidation of the carboxylated acrylonitrile moiety (organic acid) may be carried out through ionic bonding using metal oxides such as zinc oxide or other metal salts.

Crosslinking by means of covalent bonds of sulphur can significantly improve the durability of the rubber in contact with oils and chemicals. In addition, the addition of zinc oxide promotes the generation of ionic bonds of zinc ions. Ionic crosslinking by means of zinc ions will increase the tensile strength, breaking force and abrasion resistance as well as the elastic modulus of the rubber film.

In the case where the crosslinking mechanism simply depends on ionic bonds, the resistance to oils and chemicals will be reduced, resulting in a rubber product with lower quality reliability.

It is now generally taught that crosslinking of carboxylated nitrile rubber products, such as gloves, is effectively carried out by combining covalent bonding crosslinking by means of sulfur and accelerators with ionic crosslinking by means of metal oxides, such as zinc oxide or metal salts.

However, the use of accelerators during vulcanization will cause health related delayed type IV hypersensitivity problems.

It is widely known that rubber strength is improved by adding zinc dimethacrylate and/or basic zinc methacrylate to rubber to promote polymerization with an organic peroxide.

More specifically, the mixing of polybutadiene with methacrylic acid and then with zinc oxide gives a composition having improved abrasion resistance (see patent document 2, japanese patent open publication No.53-125139 and patent document 3, japanese patent open publication No. 52-121653). The non-polymerizable carboxylic acid is added to a mixture of the diene rubber, methacrylic acid, zinc oxide and the organic peroxide to obtain a blend improved in tensile strength (see patent document 4, Japanese patent open publication No. 53-85842). The NBR can be crosslinked in the absence of ionic bonds using methacrylic acid, zinc oxide and peroxide.

When crosslinked by means of zinc oxide or sulfur cure accelerators, the soft nitrile rubber products are provided with tensile strengths as high as resistance to chemicals. The resulting rubber product is softer than any conventional products (see patent document 6, Japanese patent No.3517246 or Japanese patent indication No. 2000-503292). The vulcanization accelerator is tetramethylthiuram disulfide in combination with Mercaptobenzothiazole (MBT). The resulting soft nitrile rubber, which is a relevant reaction product, therefore contains sulfur.

Carboxylated nitrile rubbers which are copolymers of acrylonitrile, butadiene and unsaturated carboxylic acids allow ionic bonds to be obtained in the carboxyl groups with zinc ions. However, it is difficult to generate covalent bond crosslinking in the compound using zinc ions. Therefore, a minimum dose of sulfur must be used to provide covalent crosslinking. More specifically, a method for producing a glove article is described in Japanese patent publication No.2002-527632 (patent document 7, in the specification thereof), in which crosslinking is effected by adding 1 to 3phr of sulfur and 0.5phr of a polyvalent metal oxide to a carboxylated nitrile rubber which is a copolymer of acrylonitrile, butadiene and an unsaturated carboxylic acid.

In U.S. patent No.6673871B2 (patent document 8, in the specification thereof), an elastomeric product such as a glove product is disclosed in which a crosslinking agent is a metal oxide such as zinc oxide without using conventional sulfur and an accelerator. The elastomer used is an uncarboxylated polybutadiene latex and the product can be vulcanized at a temperature of less than 100 c, more particularly at a temperature of less than 85 c. Corresponding Japanese patent-Japanese patent open publication No.2004-526063 (patent document 8) discloses a method in which the crosslinking of the synthetic polymer described previously is carried out without using an accelerator. More particularly, it claims a series of tests to characterize the step of forming a sulfur-free elastomeric film, wherein the vulcanization process is carried out at a temperature not higher than 85 ℃ using a metal oxide such as zinc oxide for carrying out sulfur substitution. However, sulfidation consisting mainly of metal oxides was found to be feasible only with some practical difficulties.

Non-patent document 1 ("Cross-linking carboxylic acid based nitrile rubber impregnated films", AndrewKells and BobGrobes, atex24-25, month 1 2006, Frankfurt, germany) was attached, which shows that a small amount of sulfur is required in addition to zinc oxide in order to obtain carboxylated nitrile LATEX gloves with acceptable durability properties when using a vulcanization accelerator such as the type tetramethylthiuram (TMTD), 2' -dithiobis (benzothiazole) - (MBTS), N-cyclohexylbenzothiazole-2-sulfenamide (CBS) and Zinc Diethyldithiocarbamate (ZDEC). It is apparent that durable carboxylated nitrile latex gloves are difficult to produce without the use of sulfur and sulfur-based accelerators. While published attempts have been made to make glove products from self-crosslinked materials, the self-crosslinking effect and the required method of producing the desired glove are not explained in the technical literature. It is true that the technology for carrying out self-crosslinking latices has not reached its acceptable target.

Attached non-patent document 2 ("Tailored synthetic crosslinking: Newapproachforthofsoft and retroglenggloveand for cellulose-free", Dr. SorenBuzs, LATEX23-24, 1.2008, Madrid, Spain) teaches a promising direction of the art, alternative crosslinking methods for NBR LATEX including direct covalent crosslinking by functional reactive groups (R) and ionic crosslinking by means of zinc oxide with the carboxyl groups of the NBR LATEX. More specifically, the vulcanization process essentially comprises direct covalent bonding of the polymer chains to the R bond and ionic bonding via the carboxyl group and zinc oxide. Under laboratory conditions, the sulfidation temperature can be reduced from 120 ℃ to 85 ℃. The technical direction indicates that in addition to the ionic bond bridging by carboxyl and zinc, the R bond derived from the covalent bond directly linked by the polymer chain is also characterized. Unfortunately, this approach does not explain the nature of the functional group R which functions as a covalent crosslinking and the actual method of constructing it.

Japanese patent indication No.2008-512626 (patent document 9) discloses a polymer latex produced by radical emulsion polymerization, wherein a soft phase portion has a unit structure based on isolated conjugated dienes, unsaturated monocarboxylic acids in the ethylene form, unsaturated dicarboxylic acids in the ethylene form, anhydrides, monoesters and monoamides thereof, (meth) acrylonitrile, styrene, substituted styrene, α -methylstyrene, alkyl esters having 1 to 10 carbons in (meth) acrylic acid, amides, N-methylolamide groups in (meth) acrylic acid, unsaturated compounds in the ethylene form containing ester derivatives and ether derivatives thereof, and mixtures thereof, and a hard phase portion has a unit structure based on groups respectively selected from unsaturated monocarboxylic acids in the ethylene form, unsaturated dicarboxylic acids, anhydrides, monoesters and monoamides thereof, (meth) acrylonitrile, styrene, unsaturated dicarboxylic acids, anhydrides, monoesters and monoamides thereof, Substituted styrenes, alpha-methylstyrene, (C1-C4 esters of (meth) acrylic acid, (amides of (meth) acrylic acid, and mixtures thereof.

It is assumed in the present invention that the crosslinking is performed by covalent bonds in the soft phase portion. In particular, no metal components such as zinc ions are used.

Japanese patent open publication No.2008-545814 (patent document 10) discloses an elastomer product produced by the steps of: (a) preparing a carboxylated nitrile butadiene rubber composition comprising 0.25 to 1.5 parts of zinc oxide per 100 parts of dry rubber, a base having a pH level greater than 8.5, a stabilizer, and, if desired, one or more accelerators selected from the group consisting of guanidine, dithiocarbamate and thiazole compounds, (b) immersing the shaped body in the carboxylated nitrile butadiene rubber composition, and (c) curing the carboxylated nitrile butadiene rubber product.

Crosslinking is carried out with the aid of zinc oxide. To allow the product to have the desired degree of resistance to chemicals, a crosslinking promoter is used. The vulcanization accelerator used was a dithiocarbamate. To improve the resistance to chemicals, a mixture of dithiocarbamate accelerator, diphenylguanidine and zinc mercaptobenzothiazole was used to ensure higher effectiveness. This disclosure employs crosslinking of rubber using sulfur and accelerators, producing gloves with type IV hypersensitivity problems.

The specification of US patent No.7005478 (patent document 11) discloses an elastomer product in which an elastomer having carboxyl groups is produced by the reaction of (a) a carboxylic acid or a derivative thereof, (b) a divalent or trivalent metal-containing compound and (c) an amine or amino compound and (d) a neutralizing agent for neutralizing at least a part of the carboxyl groups in the base polymer. During the reaction, no accelerator, thiuram and carbamate were used. The base polymer may be selected from natural latex rubber, synthetic latex polymers (e.g. acrylonitrile) or butadiene rubbers such as synthetic butadiene rubber and carboxylated butadiene rubber. Carboxylated acrylonitrile latex has not been used. The reaction essentially requires (c) an amine or amino compound. The amine group or amino group serves to solubilize the divalent or trivalent metal salt, which can then react with the carboxylic acid derivative to form an ionic bond. The complex solubilization process will disturb the stable reaction of ionic crosslinking.

Disclosure of the invention

The present invention overcomes the above-described problems associated with medical gloves by providing a novel vulcanization process that does not use sulfur and accelerators as the vulcanization chemical for synthesizing latex formulations. Thus, delayed hypersensitivity of type IV caused by the accelerator is prevented. Furthermore, since natural rubber latex is not used in the present invention, type I hypersensitivity caused by the presence of natural rubber latex proteins is also prevented.

The latex formulations disclosed herein comprise a base latex that is a self-crosslinked carboxylated nitrile latex or a conventional carboxylated nitrile latex, a divalent metal salt, a pH adjusting agent, an antioxidant, and a colorant. If the latex used is a conventional carboxylated nitrile latex, a pre-mixing step of the latex with methacrylic acid or a derivative thereof must be carried out. The latex of the inventive formulation is then vulcanized at elevated temperatures to provide a vulcanized film and gloves having the desired physical properties.

Carboxylated nitrile latex refers to a copolymer dispersion formed by emulsion copolymerization of butadiene, acrylonitrile, and a carboxylic acid. For carboxylated nitrile latexes having residual unsaturated butadiene moieties, the cross-links can be formed using a conventional sulfur/accelerator zinc oxide combination of the same combination used to cross-link the natural rubber. The formulations of the present invention do not use any sulfur and accelerators associated with type IV hypersensitivity. In the present invention, covalent crosslinking of the carboxylated nitrile latex is achieved by reacting the polymer with acrylic acid or its derivatives and zinc oxide.

The present inventors have found through intensive studies that the above problems can be solved by the following techniques.

(1) Manufacture of glove products having the above advantages are produced by preparing a composition characterized by mixing carboxylated acrylonitrile butadiene with methacrylic acid and zinc oxide, adjusting to pH9 to pH10 and adding water so that it contains 18-30% by weight of solid phase matter, forming a deposit of the composition on a mould or shaped body and subjecting the deposit to a cross-linking process.

If the mixing of carboxylated acrylonitrile butadiene with methacrylic acid is carried out in advance, carboxylated acrylonitrile butadiene having self-crosslinking properties can be used more easily. Using the same procedure as described above, the self-crosslinked carboxylated acrylonitrile butadiene latex is then mixed with zinc oxide, adjusted to pH9 to pH10 and water is added so as to contain 18-30% by weight of solid phase material, then the composition is shaped in the form of a deposit on a mould or former and subjected to a crosslinking process to obtain the final glove product.

(2) The glove product after the sulfur-free crosslinking process according to the present invention is made of an elastomeric rubber film having advantageous physical properties. The physical properties of the film glove products are comparable to those of conventional glove products made from elastomeric rubber films in which crosslinking is performed using zinc compounds, sulfur and accelerators. It is thus concluded from the foregoing facts that the crosslinking process according to the invention is carried out by covalent bonds based on zinc compounds (not only by ionic bonds of zinc ions) corresponding to covalent bonds by sulfur.

(a) According to the invention, the composition is prepared by mixing carboxylated acrylonitrile butadiene with methacrylic acid, mixing with zinc oxide, adjusting to a pH9 to a pH10 and dissolving in water so as to contain 18-30% by weight of solid matter, and then forming a deposit thereof on a mould or a shaped body and subjecting it to a cross-linking process.

(b) In order to ensure the production of the final rubber gloves with physical properties, it is practical to include in the formulation dispersants, antioxidants and titanium dioxide and, if desired, colorants and defoamers.

Advantages of the invention

According to the present invention, glove products can be prepared from a novel film made by mixing a carboxylated acrylonitrile butadiene latex with methacrylic acid, mixing with zinc oxide, adjusting to a pH of 9 to a pH of 10 and adding water to produce the desired total solids content, depositing onto the glove form, drying while containing a solid phase material and subjecting to a crosslinking process. One advantage of glove products made from the novel films is that the formulations used do not use any sulfur and accelerators during the vulcanization process.

Also, the glove product is almost the same or better than any conventional glove product in terms of physical properties including elastic behavior, tensile strength, elongation at break, tear strength, and approximate nail tear strength (quasi-nairtersttrength), as well as chemical properties including heat aging resistance and resistance to chemicals. Another significant advantage of the present invention is that health-related type I and type IV hypersensitivity caused by natural rubber latex proteins and accelerators, respectively, is avoided as compared to any conventional glove product that fails to overcome these problems.

Best mode for carrying out the invention

The elastomer rubber film of the present invention is produced from the following chemical composition.

The latex composition is prepared from a carboxylated acrylonitrile butadiene latex, mixed with methacrylic acid, mixed with zinc oxide, adjusted to a pH of 9 to a pH of 10, and added with water to contain a total solids content of about 18-30% by weight.

The carboxylated acrylonitrile butadiene latex contains 26 to 30 weight percent acrylonitrile, 65 to 58 weight percent butadiene and 6 to 8 weight percent methyl-methacrylic acid (total 100 weight percent).

The components and their compositional proportions are generally known. The latex is typically produced by an emulsion polymerization process.

The resulting polymer has a glass transition temperature (Tg) of substantially-15 ℃ to-30 ℃. The polymer may be obtained as a generally commercially available product including, for example, polymerLatexX-1138 supplied by polymerLatexGmbh, Nantex635t supplied by Nantex industries, and Synthomer6322 supplied by Synthomer company.

The prior mixing of the carboxylated acrylonitrile butadiene latex with methacrylic acid allows the carboxylated acrylonitrile butadiene to readily have self-crosslinking properties.

It is assumed that the carboxylated acrylonitrile butadiene mixed with methacrylic acid reacts with zinc oxide, provided that the latter is in the form of an ionomer.

The amount of methacrylic acid required should be 2 to 8% by weight. If more than 8% by weight of methacrylic acid is added outside the range of 2 to 8% by weight, it remains in the product in an unreacted state. In the case where less than 2% by weight of methacrylic acid is added, the content thereof becomes insufficient, thereby failing to provide satisfactory results.

Alternatively, if a pre-mixing step of carboxylated acrylonitrile butadiene with methacrylic acid is not performed, a self-crosslinked carboxylated acrylonitrile polybutadiene latex (e.g., 746SXL-XNRR from Synthomer) is successfully used as an alternative. It may also be selected from PureProtect by Polymer LatexGmbh and Polyac560 by ShinFaong company.

0.5 to 3.0phr of zinc oxide is added to the carboxylated acrylonitrile butadiene latex or the self-crosslinked carboxylated acrylonitrile polybutadiene latex premixed with zinc methacrylate and methacrylic acid.

The self-crosslinked carboxylated acrylonitrile butadiene latex with added zinc oxide or the carboxylated acrylonitrile butadiene latex premixed with methacrylic acid is then adjusted to a pH of 9-10. Adjusting to a pH of 9-10 includes mixing the latex with an alkaline substance that acts as a pH adjuster. The basic substance may typically be KOH. More specifically, 0.1 to 2.0% by weight of an alkaline substance is added to 100% by weight of carboxylated acrylonitrile butadiene latex.

Self-crosslinked carboxylated acrylonitrile butadiene latex of zinc oxide or premixed carboxylated acrylonitrile butadiene latex with methacrylic acid is added at about 0.1 to 2.0 weight percent dispersant per 100phr and adjusted to a pH of 9 to 10.

The dispersant may be an anionic surfactant. More specifically, the dispersant is selected from the sodium salts of naphthalenesulfonic acid polycondensates, such as TamolNN 9104.

0.1 to 1.5 wt.% antioxidant per 100phr of carboxylated acrylonitrile butadiene latex is then added to the latex mixture.

The antioxidant may be polymeric, hindered phenolic, uncolored such as WingstayL.

To whiten or color reinforce, 0.2 to 3.0 wt.% titanium dioxide per 100phr of carboxylated acrylonitrile butadiene latex is added to the carboxylated acrylonitrile butadiene latex mixture.

If desired, a colorant is added to the mixture. The colorant may be an organic dye.

The final latex composition is then adjusted with water to obtain a total solids content of about 18-30 wt%.

The following table (table 1) summarizes the proposed universal latex formulations used in the present invention.

TABLE 1 Universal latex formulation

Water adjusted to a total solids content of 18-30%

Examples of the invention

To illustrate the invention for producing elastomeric films without using sulfur and accelerators, a self-crosslinked carboxylated nitrile latex sold under the trade name Synthomer746-SXL by Synthomer was mixed with potassium hydroxide, zinc oxide, titanium dioxide, antioxidants, colorants and water in the concentrations listed in table 2. If a pre-compounded latex is used instead of the self-crosslinked latex, the pre-compounded latex is obtained by mixing 100 wt% of carboxylated acrylonitrile butadiene with 7 wt% of methacrylic acid.

Table 2 example 1 latex formulation

Example 2: production steps of gloves

Glove film articles were then produced using the compounded latex described in table 2 according to the following dipping method:

1. production of glove moldings

The process starts with cleaning the glove former, followed by a coagulant coating step in which a coagulant is applied to the glove former surface to allow the latex composition to readily adhere to the former surface before it is used in the dipping process as follows.

Hand-shaped molds or forms used in the manufacture of medical gloves are subjected to a cleaning process using a cleaning solution, brushed to remove dirt, rinsed with water and then dried.

The dry formed body is now ready for an impregnation process, which may be a direct impregnation or a coagulant impregnation process, depending on the type of product produced.

The direct dipping process first involves direct dipping of the dry formed article for the desired article into the compounded latex prepared using the formulation of the present invention.

2. The surface of the glove molding is coated with a coagulant.

For the manufacture of gloves, the shaped bodies are in the form of hands and a coagulant impregnation process is selected. The coagulant dipping process includes dipping the dried hand-shaped formed body into a coagulant bath containing calcium ions. The calcium ions are prepared as solutions of calcium nitrate or calcium chloride. The calcium ion concentration is preferably 5.0 to 20.0%, more preferably 8.0 to 17.0%. Wetting agents and detackifiers such as zinc stearate and calcium stearate are also included in the coagulant solution. The amount of wetting agent and detackifier used depends on the degree of wetting and the degree of reduction in glove tackiness desired.

3. A step of applying the (latex) composition to the glove former coated with the coagulant.

Once the moulded body is impregnated and coated with the coagulant, it is dried or partially dried at a temperature of 50 to 70 ℃ and then dipped into a tank containing a compounded latex prepared using the formulation of the invention. The shaped body is dipped for a certain time to ensure that the shaped body is properly coated and that the thickness of the glove is not too thick. The dip time of the moulded bodies in the latex tank varies between 1 and 20 seconds, preferably between 12 and 17 seconds, depending on the Total Solids Content (TSC) of the compounded latex and the thickness of the desired coating.

4. Multiple impregnation step

The latex-coated moldings are then dried at temperatures of from 80 to 120 ℃ for from 20 to 70 seconds, depending on the temperature. If dipping is required twice, the dried or partially dried latex-coated moldings are dipped again into a further latex tank containing a latex having the same formulation according to the invention. In the case of two dips, the total solids concentration of the compounded latex is reduced so that the final thickness of the glove meets the desired thickness range. The coated shaped bodies were then dried at 110 ℃ for 30 seconds.

5. Leaching process

The partially dried latex coated former was then leached in a leaching tank containing hot water (30-70 ℃) for 90-140 seconds.

6. Granulation process

Once the leaching process is completed, the latex film coated on the glove form is subjected to a pelletizing process.

7. Oven drying

The glove shaped body is now dried at a temperature of 80-120 ℃ for 300 seconds.

8. Vulcanization process

The dried latex coated shaped body is then vulcanized at 120-150 ℃ for 20-30 minutes. High temperature curing is necessary for the self-crosslinked latex to achieve the physical properties required as a formulation without any sulfur and accelerators used in conventional curing processes.

9. Post-leach step and chemical removal step

The glove former covered with the vulcanized latex film was rinsed with water to remove any residual chemicals. The post-leaching is carried out in a further leaching tank containing water at 30-80 ℃ for 60-80 seconds. This step was repeated twice.

10. Surface treatment step

After the latex film is dried and cured, it is dipped into a bath of polymer solution containing additional polymer solution to form additional coating on the latex, if desired. Where the rubber product is a glove, the polymer film may be applied to the surface of the latex glove to make the glove easy to don. Improved donning of latex gloves can also be performed using a chlorination process, which can be performed on-line on a dried and cured latex film. The in-line chlorination process generally consists of immersing the dried latex film coated former in a bath containing a chlorine solution which reacts with the outer surface of the glove. The chlorination process is performed to specifically reduce the stickiness of the glove and to make the glove easy to don. The former coated with chlorinated latex gloves is then washed and dried.

Example 3: (comparative example)

Medical gloves made from the use of self-crosslinked carboxylated acrylonitrile butadiene latex (trade name, SynthomerSCL-XNBR746, SynthomerCompany) were made according to the formulation given in table 2. The glove was compared to gloves made using conventional carboxylated acrylonitrile butadiene latex (trade name, Synthomer6322, Synthomer company) with a composition made of (1.5 wt%) ZnO and (1.0 wt%) sulfur. The ingredients including zinc oxide, dispersant, pH adjuster and antioxidant and their amounts were the same as those of the examples. The solid content obtained was 30% by weight. Glove products (trade name, Chemax) were made from the compositions using the procedure of example 2.

(example 4)

The results of the elemental analysis comparison between the glove product of the invention and the comparative product (Chemax) are shown in table 3.

Analytical testing for elements (ten elements including C, H, N, O, S, Zn, Ca, Cl, Na and K) in rubber glove test pieces was performed using a CHNO element analyzer (model EA1110, CEInstructions) with the ICP-AES system. Quantitative analysis of Zn and Ca was carried out, wherein each of the post-evaporation test pieces was accurately weighed out to 0.1g, placed in a platinum crucible, and dissolved in 2g of the mixture solution (Na)₂CO₃:Na₂B₄O₇=2:1), extracted with 30ml of hydrochloric acid, diluted to 100ml and subjected to the quantitative analysis action of an absorption analyzer. Quantitative analysis of Cl was performed in which each of the post-evaporation test pieces was accurately weighed to 1g, placed in a platinum crucible, dissolved in the Eschka mixture, extracted with 100ml of pure water, and the resulting aqueous solution thereof was subjected to quantitative analysis by an absorption analyzer. Also for the detection of sulfur, the aqueous solution was subjected to quantitative analysis by an ICP emission spectroscopic analyzer.

Table 3 comparison of the elements present in the glove

Element CHNOSZnCaClnak

The present invention is 77.99.87.13.0-Ju 0.760.760.190.010.01

Conventional 73.19.26.64.91.101.150.620.160.020.02

The symbol indicates that it cannot be detected

Sulfur content

According to the invention, the sulphur content was not detectable, whereas the conventional product Chemax contained 1.10phr of sulphur. This demonstrates that the sulfur content of the product of the invention does not show any detectable level.

Zinc content

According to the invention, the zinc content is as low as 0.76phr, whereas the conventional product V-710(KLT-C) contains 1.10phr of sulfur. This demonstrates that the zinc content of the product of the invention is low. As the amount of zinc that can be removed becomes smaller, the detrimental properties can be reduced.

(example 5)

Comparison of soluble acetone Components

The low molecular weight component in the rubber product was measured by a quantitative method of rubber solvent extraction using Soxhlet extraction for 24 hours with an acetone solvent according to jis k 6299. Quantitative analysis of the acetone extract was performed using an infrared absorption (FT-IR) spectrum analyzer.

The FT-IR analyzer was actually a Shimadzu IRPPRestage21/FTIR-8400S machine. The measurement method used the ATR technique (with diamond-shaped cells) and 40 calculation methods.

The swelling test was also conducted in accordance with jis k6310, a rubber test piece from which the soluble acetone component had been removed was immersed, the weight of the test piece increased after 72 hours at room temperature was measured and the swelling ratio of the test piece was calculated from the increased weight thereof to obtain the crosslinking density of the vulcanized rubber (i.e., it is known that the degree of crosslinking of rubber is related to the swelling ratio of rubber.

According to the invention, the soluble acetone component is 15%, whereas the conventional product Chemax contains 7.2% soluble acetone component. The swelling ratio of the product of the invention is 332%, while that of the same conventional product, Chemax, is 286%. This indicates that the crosslink density of the conventional sulfur-accelerator system is greater than the system of the present invention which does not use sulfur and an accelerator.

The presence of unreacted portions of nitrile butadiene was found from infrared analysis of the soluble acetone component. In the product of the invention, the absorption peak of the carboxylate group is about 1700cm^-1And occurs.

Example 6

The tensile properties of the carboxylated nitrile latex gloves from the present invention and conventional carboxylated nitrile latex gloves were determined using the ASTM D-6319-00 test method.

The glove was cured at 150 ℃. The sample gloves were held at 50% humidity and 23 ℃ for 24 hours. Gloves were also aged at 70 ℃ for 7 days. The tensile strength from the unaged gloves and aged gloves of the present invention and the glove from the conventional process using sulfur and accelerators are shown in tables 4 and 5, respectively.

Table 4: physical Properties of gloves produced Using the invention

Table 5: physical Properties of gloves produced Using conventional Sulfur and Accelerator formulations

The tensile strength of gloves made according to the present invention is comparable to that of gloves vulcanized using conventional sulfur and accelerator vulcanization systems. However, the elongation of the gloves produced according to the invention is higher compared to conventional products.

In summary, gloves produced according to the present invention have better aging properties than gloves produced using conventional sulfur and accelerator vulcanization systems.

The latex composition is again described.

The latex composition is prepared by using a self-crosslinked carboxylated acrylonitrile butadiene latex or a pre-compounded latex prepared by mixing a carboxylated acrylonitrile butadiene with methacrylic acid, adjusted to a pH of 9 to a pH of 10 and adjusted with water so as to contain 18-30% by weight of solids (for the total weight).

Glove products manufactured by the preceding steps using the formulation according to table 2 have the following advantages.

The method has the advantages that: type I hypersensitivity protected against rapid onset:

the product of the invention is advantageous because it does not use natural rubber latex which causes type I hypersensitivity to be induced by the presence of latex proteins.

Protection against late-onset type IV hypersensitivity:

type IV hypersensitivity results from the use of crosslinking promoters containing chemicals including thiurams, dithiocarbamates, and mercaptobenzothiazoles during glove production. The present invention does not use sulfur and accelerators during vulcanization which cause the induction of delayed type IV hypersensitivity.

The method has the advantages that: advantageous physical and chemical properties

The latex formulations according to table 2 provide latex systems with good film forming properties. This allows the glove to have a very thin film and superior protective properties. The dimensions of the glove product are as follows. Clearly, the glove product was thinner than the conventional glove (table 6).

The physical properties are shown below (Table 7). Clearly, the tensile strength and elongation at break of the products of the invention are comparable to or higher than those of conventional products.

Table 6: size of gloves from the invention

(Table 7)

Skin sensitization study (repeated damage patch test)

Although the glove made according to example 1 did not use sulfur and accelerators as a crosslinking system, a skin sensitization study was conducted to evaluate the potential of the glove to not elicit a delayed type IV hypersensitivity immune response through its contact with the skin. The delayed type IV hypersensitivity is mainly due to the use of chemicals such as accelerators during conventional vulcanization. The method used for the study was performed according to the rules described in CFR, title 21, sections 50, 56 and 312.

The objective of the study was to measure the irritation and/or sensitivity potential of the glove after repeated applications to the skin of a human subject under the closed patch test conditions. A total of 220 subjects, 35 males and 185 females, were recruited for the test.

The test was performed in two stages. During the induction phase, a square glove film sample measuring approximately 1 inch by 1 inch was placed directly on a 3M closed surgical tape. The patch was applied to the back of each subject between the scapula and the waist. This procedure was performed and repeated every monday, wednesday and friday until 9 applications of the test article. The patch was removed 24 hours after application. A 24 hour rest period after tuesday and thursday removal and a 48 hour rest period after each saturday removal. Each subject returns to the test equipment and the site is scored by the trained examiner only between the next patch applications.

At the end of the induction phase test, the test article was removed and no further tests were performed for about 2 weeks. After which the priming phase begins. The patch was applied to an untested site. After 24 hours and 72 hours of application, the response to the site at the time of removal was scored. All subjects were instructed to report any delayed skin reactivity that occurred after the last patch read.

The intensity of the skin reaction was scored according to the following scoring criteria.

Score of	Effect
		0	Has no any sign of effect
+	Hardly noticeable (minimal, fuzzy, uniform or spotty erythema)
		1	Mild (Pink uniform erythema covering most of the contact sites)
2	Medium (Pink erythema, evenly distributed throughout the contact site)
		3	Apparently (Bright red erythema with/without petechiae or papules)
4	Severe (dark red erythema, with/without vesiculation or water infiltration)

Table 8 summarizes the results of the tests performed on 220 subjects. None of the subjects showed any ill effects. Some objects (total 6) were interrupted before the test ended. It is concluded that the glove made according to example 1 does not induce clinically significant skin irritation nor shows any signs of inducing allergic contact dermatitis in human subjects. Thus, the results meet the FDA requirements for low dermatitis potential labeling requirements.

Table 8: final scoring of skin reactions induced by test strips

Conclusion

From the results shown above, it can be seen that the glove products made from the present invention are essentially identical in physical properties to any conventional sulfur/accelerator cured glove product. However, conventional glove products contain accelerators, which can induce type IV hypersensitivity. The gloves produced by the present invention do not use any of these chemicals and show no skin reaction, thereby ensuring a significant level of safety to the human body. The residual level of zinc species was found to be minimal by detection. The glove also has the additional advantage of better aging properties.

Claims (12)

1. A composition for manufacturing an elastomeric rubber glove, wherein sulfur is not detected in a test piece of the rubber glove manufactured using the composition, characterized by not containing sulfur and an accelerator for vulcanization reaction, comprising: 100 parts by weight of nitrile latex, 0.5 to 3.0 parts by weight of zinc oxide, 0.1 to 2.0 parts by weight of a pH adjusting agent to obtain a pH of 9 to 10, 0.1 to 1.5 parts by weight of an antioxidant, 0.2 to 3 parts by weight of titanium dioxide, and 0.1 to 2.0 parts by weight of a sodium salt of a naphthalenesulfonic acid polycondensate,

and the Total Solids Concentration (TSC) in the composition was 18-30%, water was used for TSC variation,

the nitrile latex is premixed with 2 to 8 wt% of methacrylic acid with respect to 100 wt% of carboxylated nitrile latex,

wherein the carboxylated nitrile latex comprises from 26 to 30 weight percent acrylonitrile, from 65 to 58 weight percent butadiene, and from 6 to 8 weight percent methacrylic acid, the sum of which is 100 weight percent.

2. The elastomeric rubber glove-making composition of claim 1, wherein the carboxylated nitrile latex is self-crosslinked.

3. The elastomeric rubber glove manufacturing composition of claim 1, wherein the antioxidant is a hindered phenol.

4. The elastomeric rubber glove manufacturing composition of claim 1, comprising a colorant.

5. A method of manufacturing elastomeric rubber gloves, the rubber gloves manufactured by the method having no detectable sulfur in test pieces, comprising the steps of:

a. the dried mould/shape is immersed for 15 seconds in a coagulant solution containing 8-17% calcium ions,

b. the mould/shaped body coated with the coagulant is dried or partially dried at 50 to 70 c,

c. immersing the coagulant-coated former/molding in the elastomer rubber glove-making composition according to claim 1 at 30 ℃ for 1 to 20 seconds, drying the latex-coated molding at 80 to 120 ℃ for 20 to 70 seconds, leaching the former/molding in a leaching tank containing hot water at 30 to 70 ℃ for 90 to 140 seconds to perform a leaching step,

d. drying the composition for manufacturing the elastomer rubber gloves at 80-120 ℃ for 250-300 seconds,

e. the elastomer rubber glove obtained by the above steps is cured for 20-30 minutes at the temperature of 120-150 ℃,

f. performing a chemical removal step of rinsing with water to remove any residual chemicals; performing a post-leaching step of water washing in a further leaching tank containing water at 30-80 ℃ for 60-80 seconds, and repeating the step twice; and then surface treatment is carried out.

6. The method of manufacturing elastomeric rubber gloves of claim 5, wherein the mold/form is a hand form.

7. The glove manufactured by the method for manufacturing an elastomeric rubber glove according to claim 5, wherein sulfur is not detected in the test piece of the manufactured rubber glove, wherein the glove has a thickness of 0.05 to 0.15 mm.

8. The glove manufactured by the method for manufacturing an elastomeric rubber glove according to claim 5, wherein sulfur is not detected in the test piece of the manufactured rubber glove, characterized by having an unaged tensile stress of 22-26MPa and an elongation at break of 580-620%.

9. The glove manufactured by the method for manufacturing an elastomeric rubber glove of claim 5, wherein sulfur is not detected in the test piece of the manufactured rubber glove, characterized by having a modulus of 500% at 10 to 15 MPa.

10. The glove produced by the method of producing elastomeric rubber gloves of claim 5, wherein no sulfur is detectable in the test pieces of the produced rubber gloves, characterized by the absence of an accelerator that produces type IV hypersensitivity.

11. The glove manufactured by the method of manufacturing an elastomeric rubber glove of claim 5, wherein no sulfur is detectable in the test pieces of the manufactured glove, characterized by reduced skin irritation as compared to conventional gloves crosslinked with sulfur and an accelerator.

12. The glove produced by the method of manufacturing elastomeric rubber gloves of claim 5, wherein sulfur is not detectable in the test pieces of the produced rubber gloves, wherein the FDA low dermatitis potential requirements are met.